Detalles de la búsqueda
1.
Immunogenicity and safety of the quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) in 2-10-year-old children: results of an open, randomised, controlled study.
Eur J Pediatr
; 172(5): 601-12, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23307281
2.
Safety and immunogenicity of a tetravalent meningococcal serogroups A, C, W-135 and Y conjugate vaccine in adolescents and adults.
Hum Vaccin
; 7(2): 239-47, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21343698
3.
Immunogenicity and safety of the Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine co-administered with human rotavirus, hepatitis A and 13-valent pneumococcal conjugate vaccines: results from a phase III, randomized, multicenter study in infants.
Hum Vaccin Immunother
; 15(2): 327-338, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30252603
4.
Immunogenicity and Safety of a Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine 6 Years After MenC Priming as Toddlers.
Pediatr Infect Dis J
; 38(6): 643-650, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31116180
5.
Antibody persistence and booster response 68â¯months after vaccination at 2-10â¯years of age with one dose of MenACWY-TT conjugate vaccine.
Vaccine
; 36(23): 3286-3295, 2018 05 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-29724511
6.
Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib and PHiD-CV When Coadministered With MenACWY-TT in Infants: Results of an Open, Randomized Trial.
Pediatr Infect Dis J
; 37(7): 704-714, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29620722
7.
Safety and Immunogenicity of the Quadrivalent Meningococcal Serogroups A, C, W and Y Tetanus Toxoid Conjugate Vaccine Coadministered With Routine Childhood Vaccines in European Infants: An Open, Randomized Trial.
Pediatr Infect Dis J
; 36(4): e98-e107, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28002359
8.
Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants.
Vaccine
; 35(28): 3564-3574, 2017 06 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-28536030
9.
Five-year Antibody Persistence and Booster Response After 1 or 2 Doses of Meningococcal A, C, W and Y Tetanus Toxoid Conjugate Vaccine in Healthy Children.
Pediatr Infect Dis J
; 35(6): 662-72, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26928521
10.
Antibody Persistence in Young Children 5 Years after Vaccination with a Combined Haemophilus influenzae Type b-Neisseria meningitidis Serogroup C Conjugate Vaccine Coadministered with Diphtheria-Tetanus-Acellular Pertussis-Based and Pneumococcal Conjugate Vaccines.
Clin Vaccine Immunol
; 23(7): 555-63, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27145999
11.
Five-year Antibody Persistence and Booster Response to a Single Dose of Meningococcal A, C, W and Y Tetanus Toxoid Conjugate Vaccine in Adolescents and Young Adults: An Open, Randomized Trial.
Pediatr Infect Dis J
; 34(11): 1236-43, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26237742
12.
Quadrivalent meningococcal (MenACWY-TT) conjugate vaccine or a fourth dose of H. influenzae-N. meningitidis C/Y conjugate vaccine (HibMenCY-TT) is immunogenic in toddlers who previously received three doses of HibMenCY-TT in infancy.
Vaccine
; 33(7): 933-41, 2015 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-25152325
13.
Immunogenicity and reactogenicity of Infanrix™ when co-administered with meningococcal MenACWY-TT conjugate vaccine in toddlers primed with MenHibrix™ and Pediarix™.
Vaccine
; 33(7): 924-32, 2015 Feb 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-25305567
14.
T-cell responses induced in normal volunteers immunized with a DNA-based vaccine containing HIV-1 env and rev.
AIDS
; 16(16): 2137-43, 2002 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-12409734
15.
Magnitude and quality of antibody response to a combination hepatitis A and hepatitis B vaccine.
Antiviral Res
; 53(1): 63-73, 2002 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-11684316
16.
Comparison of the Safety and Immunogenicity of a Novel Quadrivalent Meningococcal ACWY-Tetanus Toxoid Conjugate Vaccine and a Marketed Quadrivalent Meningococcal ACWY-Diphtheria Toxoid Conjugate Vaccine in Healthy Individuals 10-25 Years of Age.
J Pediatric Infect Dis Soc
; 3(1): 33-42, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24567843
17.
One or two doses of quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine is immunogenic in 9- to 12-month-old children.
Pediatr Infect Dis J
; 32(7): 760-7, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23348814
18.
Meningococcal polysaccharide A O-acetylation levels do not impact the immunogenicity of the quadrivalent meningococcal tetanus toxoid conjugate vaccine: results from a randomized, controlled phase III study of healthy adults aged 18 to 25 years.
Clin Vaccine Immunol
; 20(10): 1499-507, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23885033
19.
Antibody persistence and immune memory 15 months after priming with an investigational tetravalent meningococcal tetanus toxoid conjugate vaccine (MenACWY-TT) in toddlers and young children.
Hum Vaccin Immunother
; 8(7): 866-72, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22485049
20.
A tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when co-administered with Twinrix(®) in subjects aged 11-17 years: an open, randomised, controlled trial.
Vaccine
; 30(4): 774-83, 2012 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-22107850